Conference item

Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients - Permal study sub-set analysis

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Debruyne, F., Boyle, P., Vela-Navarrete, R., Da Silva, F., Teillac, P., Perrin, P., Hamdy, F., & Raynaud, J. (2004). Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients - Permal study sub-set analysis. 171(4), 243–244.

MLA Style

Debruyne, F, et al. “Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients - Permal Study Sub-Set Analysis.” vol. 171, no. 4, 2004, pp. 243–44.

Chicago Style

Debruyne, F, P Boyle, R Vela-Navarrete, et al. 2004. “Evaluation of the Clinical Benefit of Permixon and Tamsulosin in Severe BPH Patients - Permal Study Sub-Set Analysis.” 171 (4): 243–44.
Print

Authors

+ Debruyne, F More by this author

Role:: Author

+ Boyle, P More by this author

Role:: Author

+ Vela-Navarrete, R More by this author

Role:: Author

+ Da Silva, F More by this author

Role:: Author

+ Teillac, P More by this author

Role:: Author

More authors...

Host title:: JOURNAL OF UROLOGY
Volume:: 171
Issue:: 4
Pages:: 243-244
Publication date:: 2004-04-01
ISSN:: 0022-5347

Pubs id:: pubs:120772
UUID:: uuid:081558b1-7e77-4716-887a-928a4670d6a3
Local pid:: pubs:120772
Source identifiers:: 120772
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_081558b17e774716887a928a4670d6a3

Terms of use

Copyright date:: 2004

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP